Laurion Capital Management’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-17,383
| Closed | -$137K | – | 414 |
|
|
2023
Q1 | $137K | Sell |
17,383
-81,632
| -82% | -$642K | ﹤0.01% | 213 |
|
|
2022
Q4 | $669K | Sell |
99,015
-248,110
| -71% | -$1.68M | ﹤0.01% | 143 |
|
|
2022
Q3 | $5.04M | Sell |
347,125
-122,875
| -26% | -$1.78M | 0.03% | 87 |
|
|
2022
Q2 | $4.63M | Hold |
470,000
| – | – | 0.07% | 67 |
|
|
2022
Q1 | $6.93M | Hold |
470,000
| – | – | 0.08% | 60 |
|
|
2021
Q4 | $6.22M | Buy |
470,000
+350,000
| +292% | +$4.63M | 0.06% | 77 |
|
|
2021
Q3 | $2.09M | Hold |
120,000
| – | – | 0.01% | 208 |
|
|
2021
Q2 | $2.88M | Hold |
120,000
| – | – | 0.02% | 141 |
|
|
2021
Q1 | $3.08M | Buy |
+120,000
| New | +$3.08M | 0.02% | 200 |
|
|
2019
Q2 | – | Sell |
-58,871
| Closed | -$1.69M | – | 700 |
|
|
2019
Q1 | $1.69M | Buy |
58,871
+28,670
| +95% | +$821K | 0.02% | 207 |
|
|
2018
Q4 | $596K | Buy |
+30,201
| New | +$596K | 0.01% | 318 |
|